198 related articles for article (PubMed ID: 29513252)
1. Overtreatment in surgery - does it concern also the patients with ductal breast carcinoma in situ.
Nowikiewicz T; Zegarski W; Głowacka-Mrotek I
Pol Przegl Chir; 2018 Feb; 90(1):47-51. PubMed ID: 29513252
[TBL] [Abstract][Full Text] [Related]
2. Avoiding Overtreatment of Ductal Carcinoma in situ.
van der Borden CL; Stoffers S; Lips EH; Wesseling J
Trends Cancer; 2019 Jul; 5(7):391-393. PubMed ID: 31311652
[TBL] [Abstract][Full Text] [Related]
3. Preventing Overdiagnosis and Overtreatment: Just the Next Step in the Evolution of Breast Cancer Care.
Mukhtar RA; Wong JM; Esserman LJ
J Natl Compr Canc Netw; 2015 Jun; 13(6):737-43. PubMed ID: 26085389
[TBL] [Abstract][Full Text] [Related]
4. Current approach and future perspective for ductal carcinoma in situ of the breast.
Kanbayashi C; Iwata H
Jpn J Clin Oncol; 2017 Aug; 47(8):671-677. PubMed ID: 28486668
[TBL] [Abstract][Full Text] [Related]
5. Why the term 'low-grade ductal carcinoma in situ' should be changed to 'borderline breast disease': diagnostic and clinical implications.
Masood S
Womens Health (Lond); 2012 Jan; 8(1):57-62. PubMed ID: 22171775
[TBL] [Abstract][Full Text] [Related]
6. Overdiagnosis of breast cancer at screening is clinically insignificant.
Feig SA
Acad Radiol; 2015 Aug; 22(8):961-6. PubMed ID: 25797300
[TBL] [Abstract][Full Text] [Related]
7. How different terminology for ductal carcinoma in situ impacts women's concern and treatment preferences: a randomised comparison within a national community survey.
McCaffery K; Nickel B; Moynihan R; Hersch J; Teixeira-Pinto A; Irwig L; Barratt A
BMJ Open; 2015 Nov; 5(11):e008094. PubMed ID: 26525720
[TBL] [Abstract][Full Text] [Related]
8. How do we manage overdiagnosis/overtreatment in breast screening?
Wallis MG
Clin Radiol; 2018 Apr; 73(4):372-380. PubMed ID: 29174412
[TBL] [Abstract][Full Text] [Related]
9. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
[TBL] [Abstract][Full Text] [Related]
10. Overcoming Barriers in Ductal Carcinoma In Situ Management: From Overtreatment to Optimal Treatment.
Wright JL; Rahbar H; Obeng-Gyasi S; Carlos R; Tjoe J; Wolff AC
J Clin Oncol; 2022 Jan; 40(3):225-230. PubMed ID: 34813345
[No Abstract] [Full Text] [Related]
11. Overdiagnosis in breast imaging.
Evans A; Vinnicombe S
Breast; 2017 Feb; 31():270-273. PubMed ID: 28029492
[TBL] [Abstract][Full Text] [Related]
12. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Groen EJ; Elshof LE; Visser LL; Rutgers EJT; Winter-Warnars HAO; Lips EH; Wesseling J
Breast; 2017 Feb; 31():274-283. PubMed ID: 27671693
[TBL] [Abstract][Full Text] [Related]
13. Effects of awareness of breast cancer overdiagnosis among women with screen-detected or incidentally found breast cancer: a qualitative interview study.
Pickles K; Hersch J; Nickel B; Vaidya JS; McCaffery K; Barratt A
BMJ Open; 2022 Jun; 12(6):e061211. PubMed ID: 35676016
[TBL] [Abstract][Full Text] [Related]
14. Addressing overtreatment of screen detected DCIS; the LORIS trial.
Francis A; Thomas J; Fallowfield L; Wallis M; Bartlett JM; Brookes C; Roberts T; Pirrie S; Gaunt C; Young J; Billingham L; Dodwell D; Hanby A; Pinder SE; Evans A; Reed M; Jenkins V; Matthews L; Wilcox M; Fairbrother P; Bowden S; Rea D
Eur J Cancer; 2015 Nov; 51(16):2296-303. PubMed ID: 26296293
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of ductal carcinoma in situ in an era of de-escalation of therapy.
Schnitt SJ
Mod Pathol; 2021 Jan; 34(Suppl 1):1-7. PubMed ID: 32908254
[TBL] [Abstract][Full Text] [Related]
16. Analysing the ethics of breast cancer overdiagnosis: a pathogenic vulnerability.
Rogers WA
Med Health Care Philos; 2019 Mar; 22(1):129-140. PubMed ID: 30030748
[TBL] [Abstract][Full Text] [Related]
17. Controversies in Screening Mammography.
Swain M; Jeudy M; Pearlman MD
Clin Obstet Gynecol; 2016 Jun; 59(2):351-61. PubMed ID: 27101240
[TBL] [Abstract][Full Text] [Related]
18. Overdiagnosis and overtreatment of breast cancer: rates of ductal carcinoma in situ: a US perspective.
Kumar AS; Bhatia V; Henderson IC
Breast Cancer Res; 2005; 7(6):271-5. PubMed ID: 16457703
[TBL] [Abstract][Full Text] [Related]
19. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
20. Current Issues in the Overdiagnosis and Overtreatment of Breast Cancer.
Monticciolo DL; Helvie MA; Hendrick RE
AJR Am J Roentgenol; 2018 Feb; 210(2):285-291. PubMed ID: 29091010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
